Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Moxonidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NISCH known ✓ | Q9Y2I1 | 3/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 9/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 8/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 8/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 7/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | HRH2 | P25021 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 4/20 | 0.97 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.97 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.97 |
| ▸ | CFB | P00751 | 3/20 | 0.50 |
| ▸ | ADRA1D | P25100 | 5/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 5/20 | 0.46 |
| ▸ | HTR1D | P28221 | 4/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Moxonidine SCHEMBL8390103 | 1.00 | ADRA2C (1.00) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL29363838 | 1.00 | ADRA2C (1.00) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL1321306 | 0.99 | BLM (1.00) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL1230620 | 0.97 | BLM (0.97) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL30484346 | 0.97 | BLM (0.97) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL5006894 | 0.93 | ADRA2C (0.86) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL8007695 | 0.93 | ADRA2C (0.86) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| SCHEMBL2325739 | 0.90 | ADRA2C (0.81) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL6514578 | 0.89 | ADRA2C (0.80) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL8019736 | 0.89 | ADRA2C (0.80) | ADRA2CADRA2AADRA2BADRA1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4855 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704839-A2 | IMIDAZOLE CONTAINING COMPOUNDS, DERIVATIVES THEREFORE, AND USES THEREOF | ALPHERABIO LLC (US) | 2026-03-11 | — | — | EP | claimed |
| US-12503711-B2 | Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism | GENOMATICA, INC. (US) | 2025-12-23 | — | — | US | claimed |
| US-20250288558-A1 | THERAPEUTIC FOR SPINAL CORD INJURY TO INDUCE HYPOTHERMIA | THE TRUSTEES OF INDIANA UNIVERSITY | 2025-09-18 | — | — | US | claimed |
| WO-2025151848-A1 | NOVEL STABILIZED IMIDAZOLINE COMPLEXES | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250230130-A1 | NOVEL STABILIZED IMIDAZOLINE COMPLEXES | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2025-07-17 | — | — | US | claimed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | claimed |
| US-20250177354-A1 | THERAPEUTIC COMBINATIONS, COMPOSITIONS, AND METHODS FOR DESIGNING AND PRODUCING ENTACTOGENIC MINDSTATES | MINDSTATE DESIGN LABS INC (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-3359134-B1 | COMPOSITIONS AND COMPOSITIONS FOR USE IN ON-DEMAND HIGH-EFFICIENCY TRIGGERABLE ANESTHESIA | CHILDRENS MEDICAL CT CORP (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2025067458-A1 | OPHTHALMIC PHARMACEUTICAL COMPOSITION AND USE THEREOF | 苏州普乐康医药科技有限公司 | 2025-04-03 | — | — | WO | claimed |
| EP-0170193-B1 | FEEDSTUFF ADDITIVE FOR THE GROWTH PROMOTING OF AGRICULTURAL USEFUL ANIMALS | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1991-12-27 | — | — | EP | claimed |
| EP-0317855-B1 | PHARMACEUTICAL PRODUCTS | Beiersdorf Aktiengesellschaft (DE) | 1991-12-18 | — | — | EP | claimed |
| US-4952410-A | SYNERGISTIC MIXTURE; HYPOTENSIVE AGENTS; DIURETICS; SIDE EFFECT REDUCTION | BEIERSDORF AG (DE) | 1990-08-28 | — | — | US | claimed |
| US-4882163-A | Transdermal therapeutic system | BEIERSDORF AKTIENGESELLSCHAFT (DE) | 1989-11-21 | — | — | US | claimed |
| EP-0317855-A2 | Pharmaceutical products | Beiersdorf Aktiengesellschaft (DE) | 1989-05-31 | — | — | EP | claimed |
| EP-0170821-B1 | SELF-ADHESIVE PLASTER | Beiersdorf Aktiengesellschaft (DE) | 1989-03-15 | — | — | EP | claimed |
| US-4778678-A | Transdermal medicament | BEIERSDORF AG (DE) | 1988-10-18 | — | — | US | claimed |
| EP-0169364-B1 | SELF-ADHESIVE PLASTER | Beiersdorf Aktiengesellschaft (DE) | 1988-08-03 | — | — | EP | claimed |
| EP-0170010-B1 | SELF-ADHESIVE PLASTER | Beiersdorf Aktiengesellschaft (DE) | 1987-11-19 | — | — | EP | claimed |
| EP-0169364-A1 | Self-adhesive plaster | Beiersdorf Aktiengesellschaft (DE) | 1986-01-29 | — | — | EP | claimed |